δ ENaC: a novel divergent amiloride-inhibitable sodium channel
Author(s) -
Hong-Long Ji,
Runzhen Zhao,
Zai-Xing Chen,
Sreerama Shetty,
Steven Idell,
Sadis Matalon
Publication year - 2012
Publication title -
ajp lung cellular and molecular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.892
H-Index - 163
eISSN - 1522-1504
pISSN - 1040-0605
DOI - 10.1152/ajplung.00206.2012
Subject(s) - epithelial sodium channel , alternative splicing , sodium channel , amiloride , protein subunit , biology , pathological , microbiology and biotechnology , proteomics , neuroscience , genetics , bioinformatics , sodium , medicine , chemistry , gene , gene isoform , pathology , organic chemistry
The fourth subunit of the epithelial sodium channel, termed delta subunit (δ ENaC), was cloned in human and monkey. Increasing evidence shows that this unique subunit and its splice variants exhibit biophysical and pharmacological properties that are divergent from those of α ENaC channels. The widespread distribution of epithelial sodium channels in both epithelial and nonepithelial tissues implies a range of physiological functions. The altered expression of SCNN1D is associated with numerous pathological conditions. Genetic studies link SCNN1D deficiency with rare genetic diseases with developmental and functional disorders in the brain, heart, and respiratory systems. Here, we review the progress of research on δ ENaC in genomics, biophysics, proteomics, physiology, pharmacology, and clinical medicine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom